MHTX OTC
Manhattan Scientifics, Inc.
1W: +0.0%
1M: -90.0%
3M: -50.0%
YTD: -90.0%
1Y: -90.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$1K
-102.0% ▼
Operating Income
-$703K
-3.5% ▼
Net Income
-$1M
+57.3% ▲
EPS (Diluted)
$-0.00
+57.1% ▲
EBITDA
-$1M
+57.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $97K | $50K | $50K | $50K | $0 |
| YoY Growth | +0.0% | -48.5% | +0.0% | +0.0% | -100.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $1K |
| Gross Profit | $97K | $50K | $50K | $50K | -$1K |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | — |
| R&D Expenses | $8K | $11K | $10K | $11K | $10K |
| SG&A Expenses | $1M | $714K | $727K | $718K | $693K |
| Operating Expenses | $1M | $725K | $737K | $729K | $702K |
| Operating Income | -$1M | -$675K | -$687K | -$679K | -$703K |
| Operating Margin | -1056.7% | -1350.0% | -1374.0% | -1358.0% | — |
| Interest Expense | $5K | $25K | $26K | $21K | $0 |
| Income Before Tax | -$1M | $4M | -$4M | -$3M | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | $4M | -$4M | -$3M | -$1M |
| Net Margin | -1259.8% | 8628.0% | -7278.0% | -5460.0% | — |
| EPS (Diluted) | $-0.00 | $0.01 | $-0.01 | $-0.00 | $-0.00 |
| EBITDA | -$1M | $4M | -$4M | -$3M | -$1M |
| Shares Outstanding | 549M | 593M | 559M | 559M | 559M |